华润双鹤：关于全资子公司西安京西双鹤药业有限公司复方醋酸钠林格注射液获得药品注册证书的公告

Group 1 - The core point of the article is that China Resources Double Crane has announced that its wholly-owned subsidiary, Xi'an Jingxi Double Crane Pharmaceutical Co., Ltd., has received a drug registration certificate for Compound Sodium Acetate Linger Injection from the National Medical Products Administration [2] Group 2 - The announcement highlights the company's progress in obtaining regulatory approval for its pharmaceutical product, which may enhance its market position [2] - The approval of the drug registration certificate indicates compliance with national regulatory standards, potentially leading to increased sales and market access for the company [2] - This development reflects the company's ongoing commitment to expanding its product portfolio and improving its offerings in the pharmaceutical sector [2]